Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 256

1.

CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.

Nishihara Y, Aishima S, Hayashi A, Iguchi T, Fujita N, Taketomi A, Honda H, Tsuneyoshi M.

Histopathology. 2009 Oct;55(4):423-31. doi: 10.1111/j.1365-2559.2009.03398.x.

PMID:
19817893
[PubMed - indexed for MEDLINE]
2.

The current management of hilar cholangiocarcinoma.

Jarnagin WR, Fong Y, Blumgart LH.

Adv Surg. 1999;33:345-73. Review. No abstract available.

PMID:
10572576
[PubMed - indexed for MEDLINE]
3.
4.

Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).

Schmitz KJ, Lang H, Kaiser G, Wohlschlaeger J, Sotiropoulos GC, Baba HA, Jasani B, Schmid KW.

Hum Pathol. 2009 Dec;40(12):1706-14. doi: 10.1016/j.humpath.2009.01.026. Epub 2009 Aug 14.

PMID:
19683330
[PubMed - indexed for MEDLINE]
5.

Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.

Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Iguchi T, Taketomi A, Maehara Y, Tsuneyoshi M.

Hum Pathol. 2007 Dec;38(12):1819-25. Epub 2007 Sep 14.

PMID:
17854859
[PubMed - indexed for MEDLINE]
6.

Extrahepatic cholangiocarcinoma: current surgical strategy.

Boutros C, Somasundar P, Espat NJ.

Surg Oncol Clin N Am. 2009 Apr;18(2):269-88, viii. doi: 10.1016/j.soc.2008.12.003. Review.

PMID:
19306812
[PubMed - indexed for MEDLINE]
7.

Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.

Aishima S, Kuroda Y, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M.

Am J Surg Pathol. 2007 Jul;31(7):1059-67.

PMID:
17592273
[PubMed - indexed for MEDLINE]
8.

Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Cappellani A, Malfermoni G, Iacono C.

World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.

PMID:
19294467
[PubMed - indexed for MEDLINE]
9.
10.

Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.

Kim JK, Hwang HK, Park JS, Cho SI, Yoon DS, Chi HS.

J Surg Oncol. 2008 Aug 1;98(2):139-42. doi: 10.1002/jso.21089.

PMID:
18521837
[PubMed - indexed for MEDLINE]
11.

Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.

Regimbeau JM, Panis Y, Nemeth J, Pocard M, de Claviere G, Soyer P, Valleur P.

Hepatogastroenterology. 2003 Jan-Feb;50(49):21-3.

PMID:
12629982
[PubMed - indexed for MEDLINE]
12.

Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.

Sasaki R, Takeda Y, Funato O, Nitta H, Kawamura H, Uesugi N, Sugai T, Wakabayashi G, Ohkohchi N.

World J Surg. 2007 Sep;31(9):1788-96. Epub 2007 Jul 25.

PMID:
17647056
[PubMed - indexed for MEDLINE]
13.

Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.

Nakagohri T, Asano T, Kinoshita H, Kenmochi T, Urashima T, Miura F, Ochiai T.

World J Surg. 2003 Mar;27(3):289-93. Epub 2003 Feb 27.

PMID:
12607053
[PubMed - indexed for MEDLINE]
14.

Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Lee WS, Lee KW, Heo JS, Kim SJ, Choi SH, Kim YI, Joh JW.

Surg Today. 2006;36(10):892-7.

PMID:
16998683
[PubMed - indexed for MEDLINE]
16.

[Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].

Ramacciato G, Di Benedetto F, Cautero N, Masetti M, Mercantini P, Corigliano N, Nigri G, Lauro A, Ercolani G, Del Gaudio M, De Ruvo N, Pinna AD.

Chir Ital. 2004 Nov-Dec;56(6):749-59. Italian.

PMID:
15771027
[PubMed - indexed for MEDLINE]
17.

Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.

Yamaguchi K, Chijiiwa K, Saiki S, Shimizu S, Takashima M, Tanaka M.

Hepatogastroenterology. 1997 Sep-Oct;44(17):1256-61.

PMID:
9356836
[PubMed - indexed for MEDLINE]
18.

The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.

Singal AG, Rakoski MO, Salgia R, Pelletier S, Welling TH, Fontana RJ, Lok AS, Marrero JA.

Aliment Pharmacol Ther. 2010 Mar;31(6):625-33. doi: 10.1111/j.1365-2036.2009.04218.x. Epub 2009 Dec 10.

PMID:
20003093
[PubMed - indexed for MEDLINE]
19.

Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.

Itatsu K, Zen Y, Yamaguchi J, Ohira S, Ishikawa A, Ikeda H, Sato Y, Harada K, Sasaki M, Sasaki M, Sakamoto H, Nagino M, Nimura Y, Ohta T, Nakanuma Y.

Hum Pathol. 2008 May;39(5):710-9. doi: 10.1016/j.humpath.2007.09.016. Epub 2008 Mar 10.

PMID:
18329694
[PubMed - indexed for MEDLINE]
20.

Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma.

Yamanaka N, Okamoto E, Ando T, Oriyama T, Fujimoto J, Furukawa K, Tanaka T, Tanaka W, Nishigami T.

Cancer. 1995 Dec 15;76(12):2449-56.

PMID:
8625070
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk